It was known Jiangsu Lianhuan Pharmaceutical Co., Ltd. and a Britain pharmaceutical enterprise had decided to set up a joint venture called Yangzhou LianAo medicla & chemical co., ltd. to produce Eplerenone API. Recently the project had begun to construct. The factory located in Yangzhou city Hanjiang industry park and total investment is 130 million Yuan.
The first-phase project will be finished in the first half of next year to put into production. The annual sales of Eplerenone API is estimated to be 400 million Yuan.